BioSyent Inc.
RX.V
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.83% | 21.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.83% | 21.73% | |||
| Cost of Revenue | -11.00% | 56.95% | |||
| Gross Profit | -1.55% | 13.65% | |||
| SG&A Expenses | 4.09% | -47.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.90% | -40.76% | |||
| Operating Income | -11.63% | -34.30% | |||
| Income Before Tax | -9.76% | 36.77% | |||
| Income Tax Expenses | -9.76% | 27.92% | |||
| Earnings from Continuing Operations | -9.76% | 40.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.76% | 40.27% | |||
| EBIT | -11.63% | -34.30% | |||
| EBITDA | -12.61% | -38.01% | |||
| EPS Basic | -9.62% | 43.11% | |||
| Normalized Basic EPS | -9.67% | -36.29% | |||
| EPS Diluted | -9.21% | 42.23% | |||
| Normalized Diluted EPS | -9.63% | -36.49% | |||
| Average Basic Shares Outstanding | -0.13% | -1.98% | |||
| Average Diluted Shares Outstanding | -0.15% | -1.69% | |||
| Dividend Per Share | 3.74% | 8.41% | |||
| Payout Ratio | 0.15% | -0.24% | |||